A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Stage I Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer|Invasive Breast Cancer
Interventions: DRUG: Vorinostat and Tamoxifen
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Merck Sharp & Dohme LLC